<DOC>
	<DOCNO>NCT00002473</DOCNO>
	<brief_summary>RATIONALE : Kidney-sparing surgery less invasive type surgery kidney cancer , may fewer side effect improve recovery . It unknown whether kidney-sparing surgery effective kidney removal treat kidney cancer . PURPOSE : Randomized phase III trial compare effectiveness surgery completely remove kidney kidney-sparing surgery treat patient resectable kidney cancer .</brief_summary>
	<brief_title>Kidney-Sparing Surgery Compared With Kidney Removal Treating Patients With Kidney Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare time recurrence survival patient single , low stage , nonmetastatic , well localize , well delineate renal cell cancer treat partial vs radical resection . - Establish side effect kidney-sparing tumor resection term morbidity mortality patient . - Study relationship tumor size , histologic grade , histologic type , extent local control follow partial resection . - Determine prognostic factor important select candidate conservative surgery . OUTLINE : This randomize , multicenter study . Patients randomize undergo radical nephrectomy limited lymphadenectomy ( arm I ) conservative surgery ( arm II ) . Patients follow every 3 month 1 year , every 4 month 2 year , every 6 month 2 year , annually thereafter . PROJECTED ACCRUAL : A total 1300 patient accrue study 8 year .</detailed_description>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Single renal T12 tumor suspicious adenocarcinoma meet follow requirement : Solitary tumor CT scan Maximum diameter 5 cm Located negative resection margin assure N0 , M0 , i.e. , nodal involvement distant metastases No invasion renal pelvis , calices , perirenal fat determine CT scan intravenous urography Normal contralateral kidney present No von HippelLindau disease PATIENT CHARACTERISTICS : Age : Any age Performance status : WHO 02 Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No second malignancy except adequately treat nonmelanomatous skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>stage I renal cell cancer</keyword>
	<keyword>stage II renal cell cancer</keyword>
</DOC>